Dexamethasone in patients with acute lung injury from acute monocytic leukaemia

European Respiratory Journal

Volumn 39, Issue 3, 2012, Pages 648-653

  Azoulay, E ^a   Canet, E ^a   Raffoux, E ^a   Lengline E ^a   Lemiale, V ^a   Vincent, F ^a   De Labarthe, A ^a   Seguin, A ^a   Boissel, N ^a   Dombret, H ^a   Schlemmer, B ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

Acute lung injury; Acute monocytic leukaemia; Acute respiratory distress syndrome; Dexamethasone; Glucocorticoids

Indexed keywords

ANTHRACYCLINE; CYTARABINE; DEXAMETHASONE;

ACUTE LUNG INJURY; ACUTE MONOCYTIC LEUKEMIA; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; ARTIFICIAL VENTILATION; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEALTH CARE NEED; HOSPITAL INFECTION; HUMAN; INFECTION RATE; INTENSIVE CARE; LEUKOCYTOSIS; LEUKOSTASIS; LUNG INFILTRATE; MALE; MORTALITY; NEUTROPENIA; PANCYTOPENIA; PRIORITY JOURNAL;

ACUTE LUNG INJURY; ADULT; AGED; ANTINEOPLASTIC AGENTS; DEXAMETHASONE; FEMALE; HUMANS; INTENSIVE CARE UNITS; LEUKEMIA, MONOCYTIC, ACUTE; LEUKEMIC INFILTRATION; LEUKOSTASIS; LUNG; MALE; MIDDLE AGED; PANCYTOPENIA; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84860330511     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00057711     Document Type: Article

References (39)

1. Chaoui D, Legrand O, Roche N, et al. Incidence and prognostic value of respiratory events in acute leukemia. Leukemia 2004; 18: 670-675. (Pubitemid 38500184)
2. Puig N, De La Rubia J, Jarque I, et al. Characteristics of and risk factors for pneumonia in patients with hematological malignancies developing fever after autologous blood stem cell transplantation. Leuk Lymphoma 2007; 48: 2367-2374. (Pubitemid 350258302)
3. Azoulay E, Schlemmer B. Diagnostic strategy in cancer patients with acute respiratory failure. Intensive Care Med 2006; 32: 808-822. (Pubitemid 43781361)
4. Azoulay E, Thiery G, Chevret S, et al. The prognosis of acute respiratory failure in critically ill cancer patients. Medicine (Baltimore) 2004; 83: 360-370. (Pubitemid 39545182)
5. Darmon M, Thiery G, Ciroldi M, et al. Intensive care in patients with newly diagnosed malignancies and a need for cancer chemotherapy. Crit Care Med 2005; 33: 2488-2493. (Pubitemid 41682099)
6. Potenza L, Luppi M, Morselli M, et al. Leukaemic pulmonary infiltrates in adult acute myeloid leukaemia: a high-resolution computerized tomography study. Br J Haematol 2003; 120: 1058-1061. (Pubitemid 36411567)
7. Thornton KA, Levis M. Images in clinical medicine. FLT3 mutation and acute myelogenous leukemia with leukostasis. N Engl J Med 2007; 357: 1639. (Pubitemid 47598406)
8. Azoulay E, Fieux F, Moreau D, et al. Acute monocytic leukemia presenting as acute respiratory failure. Am J Respir Crit Care Med 2003; 167: 1329-1333. (Pubitemid 36609715)
9. Koh TT, Colby TV, Muller NL. Myeloid leukemias and lung involvement. Semin Respir Crit Care Med 2005; 26: 514-519. (Pubitemid 41552380)
10. Dutcher JP, Schiffer CA, Wiernik PH. Hyperleukocytosis in adult acute nonlymphocytic leukemia: impact on remission rate and duration, and survival. J Clin Oncol 1987; 5: 1364-1372.
11. Lester TJ, Johnson JW, Cuttner J. Pulmonary leukostasis as the single worst prognostic factor in patients with acute myelocytic leukemia and hyperleukocytosis. Am J Med 1985; 79: 43-48. (Pubitemid 15072945)
12. Ventura GJ, Hester JP, Smith TL, et al. Acute myeloblastic leukemia with hyperleukocytosis: risk factors for early mortality in induction. Am J Hematol 1988; 27: 34-37. (Pubitemid 18052629)
13. Lichtman MA, Rowe JM. Hyperleukocytic leukemias: rheological, clinical, and therapeutic considerations. Blood 1982; 60: 279-283. (Pubitemid 12048667)
14. Stucki A, Rivier AS, Gikic M, et al. Endothelial cell activation by myeloblasts: molecular mechanisms of leukostasis and leukemic cell dissemination. Blood 2001; 97: 2121-2129.
15. van Buchem MA, Colly LP, Hogendoorn PC, et al. Experimental myelocytic leukemia in the Brown-Norway rat as a model for pulmonary leukostasis. Am J Pathol 1991; 138: 777-780.
16. Prakash UB, Divertie MB, Banks PM. Aggressive therapy in acute respiratory failure from leukemic pulmonary infiltrates. Chest 1979; 75: 345-350. (Pubitemid 9142559)
17. Rossi GA, Balbi B, Risso M, et al. Acute myelomonocytic leukemia. Demonstration of pulmonary involvement by bronchoalveolar lavage. Chest 1985; 87: 259-260.
18. Valentino DJ 3rd, Gelfand MC, Nava VE, et al. Hypoxemic respiratory failure in a 57-year-old woman with acute monocytic leukemia. Chest 2005; 128: 3629-3633. (Pubitemid 41698703)
19. Luce JM, Montgomery AB, Marks JD, et al. Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am Rev Respir Dis 1988; 138: 62-68.
20. Bernard GR, Luce JM, Sprung CL, et al. High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med 1987; 317: 1565-1570. (Pubitemid 18014383)
21. Steinberg KP, Hudson LD, Goodman RB, et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 2006; 354: 1671-1684.
22. Meduri GU, Headley AS, Golden E, et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 1998; 280: 159-165. (Pubitemid 28498389)
23. De Botton S, Dombret H, Sanz M, et al. Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group. Blood 1998; 92: 2712-2718. (Pubitemid 28469083)
24. Kelaidi C, Chevret S, De Botton S, et al. Improved outcome of acute promyelocytic leukemia with high WBC counts over the last 15 years: the European APL Group experience. J Clin Oncol 2009; 27: 2668-2676.
25. Azoulay E, Mokart D, Lambert J, et al. Diagnostic strategy for hematology and oncology patients with acute respiratory failure: randomized controlled trial. Am J Respir Crit Care Med 2010; 182: 1038-1046.
26. Azoulay E, Alberti C, Bornstain C, et al. Improved survival in cancer patients requiring mechanical ventilatory support: impact of noninvasive mechanical ventilatory support. Crit Care Med 2001; 29: 519-525. (Pubitemid 32225292)
27. Azoulay E, Mokart D, Rabbat A, et al. Diagnostic bronchoscopy in hematology and oncology patients with acute respiratory failure: prospective multicenter data. Crit Care Med 2008; 36: 100-107.
28. Soares FA, Landell GA, Cardoso MC. Pulmonary leukostasis without hyperleukocytosis: a clinicopathologic study of 16 cases. Am J Hematol 1992; 40: 28-32.
29. McKee LC Jr, Collins RD. Intravascular leukocyte thrombi and aggregates as a cause of morbidity and mortality in leukemia. Medicine (Baltimore) 1974; 53: 463-478.
30. Tryka AF, Godleski JJ, Fanta CH. Leukemic cell lysis pneumonopathy. A complication of treated myeloblastic leukemia. Cancer 1982; 50: 2763-2770.
31. Dombret H, Hunault M, Faucher C, et al. Acute lysis pneumopathy after chemotherapy for acute myelomonocytic leukemia with abnormal marrow eosinophils. Cancer 1992; 69: 1356-1361.
32. Meduri GU, Tolley EA, Chinn A, et al. Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment. Am J Respir Crit Care Med 1998; 158: 1432-1441.
33. Meduri GU, Golden E, Freire AX, et al. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest 2007; 131: 954-963. (Pubitemid 46608692)
34. Inaba H, Pui CH. Glucocorticoid use in acute lymphoblastic leukaemia. Lancet Oncol 2010; 11: 1096-1106.
35. Ades L, Guerci A, Raffoux E, et al. Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience. Blood 2010; 115: 1690-1696.
36. Schellongowski PST, Kundi M, Laczika K, et al. Prognostic factors for intensive care unit admission, intensive care outcome, and post-intensive care survival in patients with de novo acute myeloid leukemia: a single center experience. Haematologica 2011; 96: 23.
37. Cordonnier C, Fleury-Feith J, Escudier E, et al. Secondary alveolar proteinosis is a reversible cause of respiratory failure in leukemic patients. Am J Respir Crit Care Med 1994; 149: 788-794. (Pubitemid 24082243)
38. Confalonieri M, Urbino R, Potena A, et al. Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med 2005; 171: 242-248.
39. Forghieri F, Luppi M, Morselli M, et al. Cytarabine-related lung infiltrates on high resolution computerized tomography: a possible complication with benign outcome in leukemic patients. Haematologica 2007; 92: e85-e90.